PUBLISHER: TechNavio | PRODUCT CODE: 1798140
PUBLISHER: TechNavio | PRODUCT CODE: 1798140
The AI in oncology for analytical solution market is forecasted to grow by USD 5,038.3 mn during 2024-2029, accelerating at a CAGR of 35.4% during the forecast period. The report on the AI in oncology for analytical solution market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising demand for early and accurate cancer diagnosis, acceleration of drug discovery and development, and integration of AI into clinical workflows and hospital systems.
Market Scope | |
---|---|
Base Year | 2025 |
End Year | 2029 |
Series Year | 2025-2029 |
Growth Momentum | Accelerate |
YOY 2025 | 30.1% |
CAGR | 35.4% |
Incremental Value | $5,038.3 mn |
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's AI in oncology for analytical solution market is segmented as below:
By End-user
By Type
By Application
By Geographical Landscape
This study identifies the integration of multi-omics data for precision oncology as one of the prime reasons driving the AI in oncology for analytical solution market growth during the next few years. Also, rise of real world data platforms and federated learning and expansion of AI-powered clinical decision support systems will lead to sizable demand in the market.
The report on the AI in oncology for analytical solution market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading AI in oncology for analytical solution market vendors that include BenevolentAI, ConcertAI Inc., CureMetrix Inc., DeepMind Technologies Ltd., Flatiron Health, Freenome Holdings Inc., Health Catalyst Inc., Lunit Inc., Merative L.P., Oncora Medical Inc., Owkin Inc., Paige AI Inc., PathAI Inc., Qure.AI Technologies Pvt. Ltd., Siemens AG, Tempus Labs Inc., Viz.AI Inc., and Zebra Technologies Corp.. Also, the AI in oncology for analytical solution market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Exhibits: